-
Successful Capital Raising Completed & Appendix 3B
December 20, 2007
Analytica is pleased to announce the successful completion of its Rights Issue prospectus, released to the market on September 12. A total of $1,163,369 was raised under the prospectus, which included $484,369 raised through the placement of Shortfall shares. All directors participated in the offer.
-
Appendix 3Y - Change in Director's Interest
December 14, 2007
-
Appendix 3B
December 05, 2007
-
Appendix 3Y
December 05, 2007
-
Annual General Meeting Resolution Results
November 30, 2007
-
Product Development Presentation
November 30, 2007
Powerpoint presentation delivered to shareholders at today's Annual General Meeting by Operations Manager Geoff Daly.
-
Chairman's Address at AGM
November 30, 2007
Dr. Monsour's Chairman's Address delivered at today's Annual General Meeting.
-
Company Update
November 23, 2007
-
Autostart Burette Update
November 15, 2007
Analytica Ltd is pleased to announce that its Joint Venture partner has successfully manufactured the first production-quality Autostart Burettes.
-
Form 604 - Change of Interest of Substantial Holder
November 01, 2007
Notice is given of the change of interest of substantial holder "Viralytics Limited"
-
Appendix 4C and Company Update
October 30, 2007
Analytica presents its Appendix 4C for the quarter ended 30 September 2007 and an update on developments in the Company during the quarter.
-
Annual Report and Notice of AGM
October 30, 2007
Please find attached a copy of the Company’s Annual Report and Notice of Meeting. The report and notice will be dispatched to shareholders on Wednesday 31 October 2007
-
Appendix 3B - Rights Issue Update
October 29, 2007
Analytica is pleased to announce that it has today issued a total of 45,961,367 shares and 45,266,630 free attaching Options under its Prospectus dated 12 September 2007. A total of $679,000 has been raised under the Prospectus to date.
-
Appendix 3Y - Change of Director’s Interest Notice
October 29, 2007
Analytica attaches Appendix 3Y’s for each of its Directors who have participated in the Prospectus issued on 12 September 2007.
-
Company Update - Autostart Burette
October 25, 2007
Analytica is pleased to provide an update to the market on the progress of its Autostart Burette project. Analytica has received Autostart Burette parts from our plastic injection moulding supplier. The parts will be used in a pilot production run, assembled, sterilised and packaged into complete Autostart Burettes by Analytica's Joint Venture manufacturing partner in China.
-
Analytica Ltd despatches Prospectus today
September 24, 2007
Analytica Ltd despatched the Prospectus for its non-renounceable pro-rata rights issue to raise approximately $2.2 million to shareholders today. The Prospectus was lodged with the Australian Securities & Investments Commission and ASX on 12 September 2007.
-
Corrections to Rights Issue Documentation
September 19, 2007
Analytica Limited wishes to advise of instances where incorrect date and time details appear in the Rights Issue documentation released to the market on 12 September 2007.
-
Letter to Eligible Shareholders re: Rights Issue
September 12, 2007
-
Letter to Non-Eligible Shareholders re: Rights Issue
September 12, 2007
-
Prospectus
September 12, 2007
-
Letter to Option Holders re: Rights Issue
September 12, 2007
-
Appendix 3B - New Issue Announcement
September 12, 2007
-
Appendix 4E - Preliminary Final Report, year ended 30 June 2007
August 30, 2007
-
Autostart Burette Project Update
August 20, 2007
In early August, Analytica’s Operations Manager visited the manufacturing plant of Analytica Limited Joint Venture partner Zhejiang Lingyang Medical Apparatus Co. in Linhai City Province, China. The purpose of the visit was to make final arrangements for the Autostart Burette pilot production run.
-
Form 605 - Ceasing to be a substantial shareholder
August 02, 2007
-
Quarterly cash flow- Appendix 4C
July 31, 2007
-
Naltrexone Presentation
July 10, 2007
-
Autostart Burette Presentation
July 10, 2007
-
Appendix 3B
June 27, 2007
New issue announcement, application for quotation of additional securities and agreement
-
Project Update - Autostart Burette
June 14, 2007
Analytica is pleased to announce the commencement of the pilot production program for the Autostart Burette project, and has applied for trademark registration for the Autostart Burette name.
-
Notice of change of interests of substantial holder
May 24, 2007
-
Change of Director's Interest - Appx 3Y
April 27, 2007
-
Quarterly Cash Flow Appendix 4C and Company Update
April 24, 2007
-
Notice of change of interests of substantial holder - Viralytics
March 30, 2007
Shares issued by Analytica Ltd to acquire Recovery Clinics Ltd has resulted in a reduction in Viralytics percentage holding in Analytica from 24.4% to 23.3%
-
Change of Director’s Interest Notice
March 30, 2007
-
Acquisition of Recovery Clinic
March 23, 2007
Analytica is pleased to announce that the Independent Directors have finalised the purchase of Recovery Clinic Pty Ltd. Recovery Clinic is a company developing a Naltrexone implant for the treatment of drug and alcohol addictions.
-
Product Update
March 20, 2007
Analytica is pleased to announce that it has successfully completed in-house verification testing on its Constant Flow Device (CFD).
-
Form 604 - Notice of change of interest of substantial holder
March 16, 2007
-
Clarification
March 09, 2007
The directors of Analytica wish to correct an error contained in the announcement made on January 2 concerning the recent Share Purchase Plan
-
Company Update
March 07, 2007
The Company wishes to advise that it has withdrawn its offer to potentially acquire the issued capital of InJet Digital Aerosols Limited (IDAL), as announced to the market on 30 November 2006. ... The Company is progressing with the proposed acquisition of Recovery Clinics Pty Ltd, also announced on 30 November 2006.
-
Appendix 4D - Half Year Report
February 28, 2007
Half Year Report for the 6 months ended December 2006
-
Corrected Appendix 3B
February 20, 2007
Analytica wishes to advise that the Appendix 3B lodged 19 February contains a typographical error. The correct number of shares issued as a result of the share purchase plan was 15,912,316. The total number of shares now on issue is 188,191,254.
-
Appendix 3B
February 19, 2007
Analytica wishes to advise that it has today issued 15,912,336 new shares subscribed for during the recent share purchase plan. $365,983 was raised via the share purchase plan.
-
Quarterly Cash Flow- Appendix 4C
January 31, 2007
Attached is the December quarter 2006 cash flow- Appendix 4c.
-
Share Purchase Plan
January 02, 2007
An invitation to shareholders to participate in a share purchase plan (Plan) which will allow Eligible Shareholders the opportunity to purchase up to $5,000 of Analytica ordinary shares without brokerage or transaction costs.
